✦ LIBER ✦

PDB22 EVALUATING THE LONG-TERM COST-EFFECTIVENESS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN IN PATIENTS WITHTYPE 2 DIABETES IN SPAIN AND ITALY

✍ Scribed by K Erny-Albrecht; G Goodall; C Townsend; R Kotchie; S Nielsen; WJ Valentine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB22 LONG-TERM COST-EFFECTIVENESS OF IN

✍ ME Minshall; NS Twena; L Nicklasson; S Roze 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

ED2 LONG-TERM COST-UTILITY ANALYSIS OF I

✍ G Goodall; WJ Valentine; C Townsend; R Kotchie; S Nielsen; K Erny-Albrecht 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PDB63 ESTIMATING THE LONG-TERM CLINICAL

✍ K Erny-Albrecht; G Goodall; S Nielsen; C Townsend; R Kotchie; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PDB30 EVALUATING THE COST-EFFECTIVENESS

✍ D Tucker; WJ Valentine; S Nielsen; C Townsend; R Kotchie; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PDB27 COST-EFFECTIVENESS OF BIPHASIC INS

✍ M Lynch; H Scheijbeler; R Kotchie; S Nielsen; J White; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PDB51 COST-EFFECTIVENESS OF EXENATIDE VE

✍ JL Palmer; CG Pinto; R Duarte; L Miguel; Z Gregor 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB